Chemoradiation for adenocarcinoma of the anus

International Journal of Radiation Oncology Biology Physics

Volumn 55, Issue 3, 2003, Pages 669-678

  Papagikos, Michael ^a   Crane, Christopher H ^b   Skibber, John ^b   Janjan, Nora A ^b   Feig, Barry ^b   Rodriguez Bigas, Miguel A ^b   Hung, Arthur ^b   Wolff, Robert A ^b   Delclos, Marc ^b   Lin, Edward ^b   Cleary, Karen ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adenocarcinoma; Anal cancer; Chemoradiation; Radiotherapy

Indexed keywords

CHEMOTHERAPY; PATIENT TREATMENT; RADIATION; RADIOTHERAPY;

CHEMORADIATION;

TUMORS;

CISPLATIN; FLUOROURACIL;

ADENOCARCINOMA; ADULT; AGED; ANUS CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE CONTROL; EPIDERMOID TUMOR; FEMALE; HISTOLOGY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RECTUM ABDOMINOPERINEAL RESECTION; RECURRENCE RISK; SURGICAL TECHNIQUE; TISSUE SECTION; TUMOR BIOPSY;

EID: 0037361252     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)04118-4     Document Type: Article

References (30)

1. Basik M., Rodriguez-Bigas M.A., Penetrante R., et al. Prognosis and recurrence patterns of anal adenocarcinoma. Am J Surg. 169:1995;233-237.
2. Jensen S.L., Shokouh-Amiri M.H., Hagen K., et al. Adenocarcinoma of the anal ducts A series of 21 cases . Dis Colon Rectum. 31:1988;268-272.
3. Joon D.L., Chao M.W., Ngan S.Y., et al. Primary adenocarcinoma of the anus A retrospective analysis . Int J Radiat Oncol Biol Phys. 45:1999;1199-1205.
4. Behan W.M., Burnett R.A. Adenocarcinoma of the anal glands. J Clin Pathol. 49:1996;1009-1011.
5. Wolff P., Peiffert D. In regard to Joon et al. IJROBP 1999;45:1199-1205. Int J Radiat Oncol Biol Phys. 49:2001;1517.
6. Myerson R.J., Karnell L.H., Menck H.R. The National Cancer Data Base report on carcinoma of the anus. Cancer. 80:1997;805-815.
7. Boman B.M., Moertel C.G., O'Connell M.J., et al. Carcinoma of the anal canal A clinical and pathologic study of 188 cases . Cancer. 54:1984;114-125.
8. Greenall M.J., Quan S.H., DeCosse J.J. Epidermoid cancer of the anus. Br J Surg. 72:(Suppl.):1985;S97-S103.
9. Greenall M.J., Quan S.H., Stearns M.W., et al. Epidermoid cancer of the anal margin Pathologic features, treatment, and clinical results . Am J Surg. 149:1985;95-101.
10. Greenall M.J., Quan S.H., Urmacher C., et al. Treatment of epidermoid carcinoma of the anal canal. Surg Gynecol Obstet. 161:1985;509-517.
11. Flam M., John M., Pajak T.F., et al. Role of mitomycin in combination with fluorouracil and radiotherapy and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal Results of a phase III randomized intergroup study . J Clin Oncol. 14:1996;2527-2539.
12. Nigro N.D., Vaitkevicius V.K., Considine B. Jr. Combined therapy for cancer of the anal canal A preliminary report - 1974 . Dis Colon Rectum. 36:1993;709-711.
13. Bartelink H., Roelofsen F., Eschwege F., et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups . J Clin Oncol. 15:1997;2040-2049.
14. Epidermoid anal cancer Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin . Lancet. 348:1996;1049-1054.
15. Bosset J.F., Pavy J.J., Roelofsen F., et al. Combined radiotherapy and chemotherapy for anal cancer. Lancet. 349:1997;205-206.
16. Cabrera A., Tsukada Y., Pickren J.W. Adenocarcinomas of the anal canal and peri-anal tissues. Ann Surg. 164:1966;152-156.
17. Merlini M., Eckert P. Malignant tumors of the anus A study of 106 cases . Am J Surg. 150:1985;370-372.
18. Welch J.P., Malt R.A. Appraisal of the treatment of carcinoma of the anus and anal canal. Surg Gynecol Obstet. 145:1977;837-841.
19. Abel M.E., Chiu Y.S., Russell T.R., et al. Adenocarcinoma of the anal glands Results of a survey . Dis Colon Rectum. 36:1993;383-387.
20. Tarazi R., Nelson R.L. Anal adenocarcinoma A comprehensive review . Semin Surg Oncol. 10:1994;235-240.
21. Anthony T., Simmang C., Lee E.L., et al. Perianal mucinous adenocarcinoma. J Surg Oncol. 64:1997;218-221.
22. Klas J.V., Rothenberger D.A., Wong W.D., et al. Malignant tumors of the anal canal The spectrum of disease, treatment, and outcomes . Cancer. 85:1999;1686-1693.
23. Mesko T.W., Rodriguez-Bigas M.A., Petrelli N.J. Inguinal lymph node metastases from adenocarcinoma of the rectum. Am J Surg. 168:1994;285-287.
24. Graham R.A., Hohn D.C. Management of inguinal lymph node metastases from adenocarcinoma of the rectum. Dis Colon Rectum. 33:1990;212-216.
25. Wolmark N., Rockette H., Mamounas E., et al. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon Results from National Surgical Adjuvant Breast and Bowel Project C-04 . J Clin Oncol. 17:1999;3553-3559.
26. O'Connell M.J., Mailliard J.A., Kahn M.J., et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol. 15:1997;246-250.
27. Saltz L.B., Cox J.V., Blanke C., et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med. 343:2000;905-914.
28. Douillard J.Y., Cunningham D., Roth A.D., et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer A multicentre randomised trial . Lancet. 355:2000;1041-1047.
29. de Gramont A., Figer A., Seymour M., et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 18:2000;2938-2947.
30. Giacchetti S., Perpoint B., Zidani R., et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol. 18:2000;136-147.